https://www.live-feeds.com/feed/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-availableContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-availablehttps://www.live-feeds.com/feed/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available#u51541Sat, 29 Aug 2026 08:56:36 +0000The FDA has cleared Moderna's first mRNA influenza vaccine for adults aged 50 and older. The vaccine is intended for use ahead of the 2026-27 season and demonstrated 27% higher efficacy than standard flu shots. While Moderna targets a quick rollout, specific distribution dates for the general public are not yet detailed. This approval coincides with the FDA's recent authorization of updated COVID-19 vaccines for the same season to address current viral strains.Why it mattersThis marks the first time mRNA technology, previously used for COVID-19, is applied to prevent influenza. The t https://www.live-feeds.com/feed/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-availablehttps://www.live-feeds.com/feed/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available#u48096Tue, 25 Aug 2026 08:20:51 +0000The FDA has approved a new mRNA flu vaccine developed by Moderna. This vaccine is available for older adults this year. While the approval marks a shift in influenza prevention technology, specific distribution dates and wide-scale availability details remain limited in current reports. The product represents the first application of mRNA technology for flu prevention following the success of COVID-19 vaccines.Why it mattersTraditional flu shots typically use inactivated viruses or proteins. mRNA vaccines provide a different mechanism for triggering immune responses. This approval allows Moder